HIGHLIGHTS
- who: Fabrice Jardin from the INSERM, Henri Becquerel Center, IRIB, Normandy University, Rouen, France have published the research: NFkB Pathway and Hodgkin Lymphoma, in the Journal: Biomedicines 2022, 10, 2153. of /2022/
- what: The authors provide an overview of the mechanisms and consequences of NFkB pathway dysregulation in HL and their potential therapeutic relevance.
SUMMARY
The tumor cells that drive this neoplasia, namely, Hodgkin and Reed-Sternberg (HRS) cells, display hallmark features that include their rareness in contrast with an extensive and rich reactive microenvironment, their loss of B-cell phenotype . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.